Full Text View
Tabular View
No Study Results Posted
Related Studies
Outpatient Treatment Of Deep Venous Thrombosis (DVT) Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
This study has been terminated.
Study NCT00041782   Information provided by M.D. Anderson Cancer Center
First Received: July 16, 2002   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplasms
Deep Vein Thrombosis
Additional conditions recognized in this trial
Thrombosis
Venous Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Vascular Diseases
Interventions listed in this trial
Dalteparin (Fragmin)
Additional drug interventions recognized in this trial
Dalteparin
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Brookdale University Hospital Medical Center
Josephine Ford Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services